LNSR 8-K 2026-11-10

LENSAR, Inc. (LNSR) 8-K dated 2026-11-10 — accession 0001193125-26-454424.

LENSAR, Inc. (LNSR) is a medical devices company listed on US.

LNSR revenue $14.1M, +17% YoY

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LNSR revenue for 2025-12-31 was $58.4M. Net income was -$34.3M. Revenue was up 9.2% from 2024-12-31 to 2025-12-31. LNSR currently screens at market cap $156.7M.

Not investment advice. The LNSR SEC hub lists recent forms. The stock page is the research view.